zofran litigation

  • Date: Mar 11, 2016
  • Category: Legal

Death Of Birth Defect Researcher Saddens Zofran Lawsuit Plaintiffs

Zofran lawsuit plaintiffs have learned that a top birth defect researcher recently passed away unexpectedly. Continue reading →

  • Date: Mar 07, 2016
  • Category: Legal

Zofran Lawsuit Numbers Are Expected To Continue Growing

The number of lawsuits filed against GlaxoSmithKline is expected to continue growing even after the discovery and trial phases begin. Continue reading →

  • Date: Mar 01, 2016
  • Category: Legal

Zofran Lawsuit Plaintiffs May Have To Prove Use Of Brand Name Drug

GSK has submitted a request that all plaintiffs involved in MDL 2657 show proof they took the brand name drug Zofran, and not a generic version. Continue reading →

  • Date: Feb 26, 2016
  • Category: Legal

Family Speaks About Their Zofran Lawsuit Hoping To Help Others

The parents of a young boy are speaking out against GlaxoSmithKline and the drug Zofran. Continue reading →

  • Date: Feb 19, 2016
  • Category: Legal

Zofran Lawsuit Plaintiffs Question Why Doctors Can Prescribe Drugs “Off-Label”

Plaintiffs involved in the ongoing Zofran birth defect lawsuits are wondering why doctors around the country are able to prescribe drugs “off-label”. Continue reading →

  • Date: Feb 05, 2016
  • Category: Legal

Zofran Lawsuit Update: Canadian Drug Label Differs From U.S.

The plaintiffs who have filed a Zofran lawsuit have found that the Canadian label for the drug warns pregnant women to not use the drug. Continue reading →

  • Date: Jan 22, 2016
  • Category: Legal

Motion Filed By GSK Attempts To Dismiss Zofran Lawsuit

GlaxoSmithKline has filed a motion requesting that Judge F. Dennis Saylor dismiss all Zofran lawsuits consolidated in MDL 2657. Continue reading →

  • Date: Jan 15, 2016
  • Category: Legal

Zofran Lawsuit Update: Another Study Links Drug To Birth Defects

As the Zofran litigation continues to grow, another study has linked the drug to birth defects. Continue reading →

  • Date: Jan 08, 2016
  • Category: Legal

Zofran Lawsuit Update: Plaintiffs Discover The CDC Tracks Birth Defects

Zofran plaintiffs have discovered that the CDC has been tracking birth defects in 41 states. Continue reading →

  • Date: Jan 01, 2016
  • Category: Legal

Zofran Lawsuit Facts: Waiver Of Formal Service Of Process Ordered

The Honorable Judge F. Dennis Saylor IV has issued an order waiving formal service of process for GlaxoSmithKline. Continue reading →

  • Date: Dec 25, 2015
  • Category: Legal

Zofran Lawsuit Alleges GSK Knew Drug Was Unsafe For Unborn Children

A California lawsuit has alleged that GlaxoSmithKline was aware that Zofran had the potential to harm unborn children prior to marketing their product as safe and effective. Continue reading →

  • Date: Dec 18, 2015
  • Category: Legal

Zofran Lawsuit Claims Right Hypoplastic Heart Syndrome Caused By Drug

A mother has claimed that her son required a heart transplant because the drug Zofran caused a severe birth defect while he was still in the womb. Continue reading →

  • Date: Mar 17, 2015
  • Category: Legal

Monheit Law Releases A 12 Point Guide To Zofran Birth Defect Lawsuits

In order to better inform the public, a national coalition of distinguished plaintiffs’ attorneys has released a comprehensive guide on litigation surrounding GlaxoSmithKline’s popular anti-nausea drug Zofran. Recent studies have begun to establish a link between Zofran’s active ingredient, Ondansetron, and severe birth defects including cleft palate and congenital heart defects. Now, recently-filed lawsuits (filed under case numbers 1:15-cv-10429 and 2:15-cv-00709PD) claim that GlaxoSmithKline was aware of Zofran’s risks, but unlawfully marketed the drug to obstetricians and gynecologists as a safe treatment for morning sickness. Continue reading →

National Alliance of Attorneys Filing Zofran Birth Defect Lawsuits

A national alliance of plaintiffs’ attorneys have begun filing Zofran birth defect lawsuits. Several independent studies have linked Zofran to a potential increased risk of child birth defects such as cleft palate, and congenital heart defects. Continue reading →